Skip to main content
SpringerLink
Log in

Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5

  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

Tumor location can profoundly affect morbidity and patient prognosis, even for the same tumor type. Very little is known about whether tumor location is determined stochastically or whether genetic risk factors can affect where tumors arise within an organ system. We have taken advantage of the Nf1−/+;Trp53−/+cis mouse model of astrocytoma/glioblastoma to map genetic loci affecting whether astrocytomas are found in the spinal cord. We identify a locus on distal Chr 5, termed Scram1 for spinal cord resistance to astrocytoma modifier 1, with a LOD score of 5.0 and a genome-wide significance of P < 0.004. Mice heterozygous for C57BL/6J×129S4/SvJae at this locus show less astrocytoma in the spinal cord compared to 129S4/SvJae homozygous mice, although we have shown previously that 129S4/SvJae mice are more resistant to astrocytoma than C57BL/6J. Furthermore, the astrocytomas that are found in the spinal cord of Scram1 heterozygous mice arise in older mice. Because spinal cord astrocytomas are very rare and difficult to treat, a better understanding of the genetic factors that govern astrocytoma in the spine may lead to new targets of therapy or prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Bailey JS, Grabowski-Boase L, Steffy BM, Wiltshire T, Churchill GA, Tarantino LM (2008) Identification of quantitative trait loci for locomotor activation and anxiety using closely related inbred strains. Genes Brain Behav 7:761–769

    Article  PubMed  CAS  Google Scholar 

  • Benes V 3rd, Barsa P, Benes V Jr, Suchomel P (2009) Prognostic factors in intramedullary astrocytomas: a literature review. Eur Spine J 18:1397–1422

    Article  PubMed  Google Scholar 

  • Binder BR, Mihaly J (2008) The plasminogen activator inhibitor “paradox” in cancer. Immunol Lett 118:116–124

    Article  PubMed  CAS  Google Scholar 

  • Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19:889–890

    Article  PubMed  CAS  Google Scholar 

  • Calzolari F, Malatesta P (2010) Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20:527–538

    Article  PubMed  CAS  Google Scholar 

  • Cao Y, Lathia JD, Eyler CE, Wu Q, Li Z, Wang H, McLendon RE, Hjelmeland AB, Rich JN (2010) Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance. Genes Cancer 1:50–61

    Article  PubMed  CAS  Google Scholar 

  • Caplan J, Pradilla G, Hdeib A, Tyler BM, Legnani FG, Bagley CA, Brem H, Jallo G (2006) A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Neurosurgery 59:193–200 discussion 193–200

    Article  PubMed  Google Scholar 

  • Chastre E, Abdessamad M, Kruglov A, Bruyneel E, Bracke M, Di Gioia Y, Beckerle MC, van Roy F, Kotelevets L (2009) TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness. FASEB J 23:916–928

    Article  PubMed  CAS  Google Scholar 

  • Chen TC, Hinton DR, Zidovetzki R, Hofman FM (1998) Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest 78:165–174

    PubMed  CAS  Google Scholar 

  • Ellis JA, Canoll P, McCormick PC 2nd, Feldstein NA, Anderson RC, Angevine PD, Kaiser MG, McCormick PC, Bruce JN, Ogden AT (2011) Platelet-derived growth factor receptor (PDGFR) expression in primary spinal cord gliomas. J Neurooncol. doi:10.1007/s11060-011-0666-6

  • Han X, Stewart JE Jr, Bellis SL, Benveniste EN, Ding Q, Tachibana K, Grammer JR, Gladson CL (2001) TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Oncogene 20:7976–7986

    Article  PubMed  CAS  Google Scholar 

  • Harrop JS, Ganju A, Groff M, Bilsky M (2009) Primary intramedullary tumors of the spinal cord. Spine (Phila Pa 1976) 34:S69–S77

    Article  Google Scholar 

  • Hitoshi Y, Harris BT, Liu H, Popko B, Israel MA (2008) Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord. Cancer Res 68:8507–8515

    Article  PubMed  CAS  Google Scholar 

  • Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AE, Barnholtz-Sloan JS (2011) Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results study. J Neurosurg Spine 14:742–747

    Article  PubMed  Google Scholar 

  • Huang CH, Yang WH, Chang SY, Tai SK, Tzeng CH, Kao JY, Wu KJ, Yang MH (2009) Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 11:1371–1382

    PubMed  CAS  Google Scholar 

  • Kawa S, Fujimoto J, Tezuka T, Nakazawa T, Yamamoto T (2004) Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells 9:219–232

    Article  PubMed  CAS  Google Scholar 

  • Lucci-Cordisco E, Zito I, Gensini F, Genuardi M (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122A:325–334

    Article  PubMed  Google Scholar 

  • Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA (2010) Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study. J Neurooncol 98:83–92

    Article  PubMed  Google Scholar 

  • Mock BA, Krall MM, Dosik JK (1993) Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci USA 90:9499–9503

    Article  PubMed  CAS  Google Scholar 

  • Mohyeldin A, Dalgard CL, Lu H, McFate T, Tait AS, Patel VC, Wong K, Rushing E, Roy S, Acs G, Verma A (2007) Survival and invasiveness of astrocytomas promoted by erythropoietin. J Neurosurg 106:338–350

    Article  PubMed  CAS  Google Scholar 

  • Noren NK, Pasquale EB (2007) Paradoxes of the EphB4 receptor in cancer. Cancer Res 67:3994–3997

    Article  PubMed  CAS  Google Scholar 

  • Peres EA, Valable S, Guillamo JS, Marteau L, Bernaudin JF, Roussel S, Lechapt-Zalcman E, Bernaudin M, Petit E (2011) Targeting the erythropoietin receptor on glioma cells reduces tumour growth. Exp Cell Res 317(16):2321–2332

    Article  PubMed  CAS  Google Scholar 

  • Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T (2000) Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet 26:109–113

    Article  PubMed  CAS  Google Scholar 

  • Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T (2004) Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci USA 101:13008–13013

    Article  PubMed  CAS  Google Scholar 

  • Ridley AJ (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16:522–529

    Article  PubMed  CAS  Google Scholar 

  • Sharma S, Free A, Mei Y, Peiper SC, Wang Z, Cowell JK (2010) Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH. Exp Mol Pathol 89:169–174

    Article  PubMed  CAS  Google Scholar 

  • Smith R, Sheppard K, DiPetrillo K, Churchill G (2009) Quantitative trait locus analysis using J/qtl. Methods Mol Biol 573:175–188

    Article  PubMed  CAS  Google Scholar 

  • Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R et al (1994) Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103–107

    Article  PubMed  CAS  Google Scholar 

  • Walrath JC, Fox K, Truffer E, Gregory Alvord W, Quinones OA, Reilly KM (2009) Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Mamm Genome 20:214–223

    Article  PubMed  CAS  Google Scholar 

  • Wang Y, Yao M, Zhou C, Dong D, Jiang Y, Wei G, Cui X (2010) Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 167:750–757

    Article  PubMed  CAS  Google Scholar 

  • Zhang K, Kagan D, DuBois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA (2009) Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. Blood 114:2952–2960

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank M. Anvers, R. Tuskan, K. Smith, K. Fox, and E. Truffer for technical assistance and D. Louis and G. Jallo for helpful discussions. JCAVS is a predoctoral student in the Graduate Partnership Program of the NIH and the Institute for Biomedical Sciences at George Washington University. This work is from a dissertation to be prepared in partial fulfillment of the requirements for the PhD degree. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsements by the US Government. This work was funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (ZIA BC 010539 to KMR), federal funds from the National Cancer Institute to SAIC Frederick (contract N01-CO-12400), federal contract from the National Institutes of Health to The Johns Hopkins University (contract HHSN268200782096C), and extramural funding from the National Institutes of Health (R01 GM074244 to KWB).

Author information

Authors and Affiliations

  1. Mouse Cancer Genetics Program, National Cancer Institute, West 7th St. at Fort Detrick, P.O. Box B, Frederick, MD, 21702, USA

    Jessica Amlin-Van Schaick & Karlyne M. Reilly

  2. Institute for Biomedical Sciences, George Washington University, Washington, DC, 20037, USA

    Jessica Amlin-Van Schaick

  3. Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, WI, 53706, USA

    Sungjin Kim & Karl W. Broman

Authors
  1. Jessica Amlin-Van Schaick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sungjin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karl W. Broman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karlyne M. Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karlyne M. Reilly.

Additional information

First two authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amlin-Van Schaick, J., Kim, S., Broman, K.W. et al. Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. Mamm Genome 23, 277–285 (2012). https://doi.org/10.1007/s00335-011-9380-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-011-9380-0

Keywords

Search

Navigation